(Q40432284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Rafael de la Torre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Beatriz Goni-Allo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Brian O Mathúna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mireia Segura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Berta Lasheras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Norberto Aguirre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

12 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

number of pages

16

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

263-278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis

29 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-1027-1

Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).

21 January 2018

1 reference

12 December 2020

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors

1 reference

12 December 2020

Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink

1 reference

12 December 2020

Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

1 reference

12 December 2020

Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

1 reference

12 December 2020

Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

12 December 2020

Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.

1 reference

12 December 2020

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones

1 reference

12 December 2020

Brain concentrations of d-MDMA are increased after stress

1 reference

12 December 2020

2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations

1 reference

12 December 2020

N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats

1 reference

12 December 2020

Elevated environmental temperature and methamphetamine neurotoxicity

1 reference

12 December 2020

Causes and consequences of methamphetamine and MDMA toxicity

1 reference

12 December 2020

MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature

1 reference

12 December 2020

Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat.

1 reference

12 December 2020

Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity

1 reference

12 December 2020

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

1 reference

12 December 2020

Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

12 December 2020

Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

1 reference

12 December 2020

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

Reactive oxygen species and the central nervous system

1 reference

12 December 2020

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

1 reference

12 December 2020

Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.

1 reference

12 December 2020

Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.

1 reference

12 December 2020

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

1 reference

12 December 2020

L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

1 reference

12 December 2020

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector

1 reference

12 December 2020

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

1 reference

12 December 2020

Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

1 reference

12 December 2020

Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats

1 reference

12 December 2020

Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX

1 reference

12 December 2020

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

12 December 2020

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

1 reference

12 December 2020

Raves: a review of the culture, the drugs and the prevention of harm.

1 reference

12 December 2020

Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration

1 reference

12 December 2020

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat

1 reference

12 December 2020

Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts.

1 reference

12 December 2020

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity

1 reference

12 December 2020

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

1 reference

12 December 2020

The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration

1 reference

12 December 2020

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

12 December 2020

Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells

1 reference

12 December 2020

Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity

1 reference

12 December 2020

Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia

1 reference

12 December 2020

Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions

1 reference

12 December 2020

The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity

1 reference

12 December 2020

Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase

1 reference

12 December 2020

Ecstasy: are animal data consistent between species and can they translate to humans?

1 reference

12 December 2020

2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.

1 reference

12 December 2020

10.1007/S00213-007-1027-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074122%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 December 2019

1013729656

0 references

1 reference